Analyst Biren Amin works at JEFFERIES and is focused on the Healthcare sector with 312 price targets and ratings documented since 2012 spanning on 25 stocks. Analyst's average stock valuation to be materialised ratio is 54.1% with an average time for price targets to be met of 136.09 days.
Most recent stock forecast was given on LUMO, Lumos Pharma Inc. at 08-Dec-2022.
Biren Amin best performing recommendations are on ALLO (ALLOGENE THERAPEUTICS, INC).
The best stock recommendation documented was for ALLO (ALLOGENE THERAPEUTICS, INC) at 11/5/2018. The price target of $31 was fulfilled within 1 day with a profit of $2.65 (9.35%) receiving and performance score of 93.47.
Average potential price target upside